Rosetta Genomics

Rosetta Genomics and NIH sign collaboration agreement

pharmaceutical-business-review.com     Aug 22, 2008   6 related          

Rosetta Genomics has signed collaboration agreement with the National Institute of Health to identify microRNAs involved in the progression of the human immunodeficiency virus, which may be used as potential drug targets.                    

InPlay: Ross Stores reports EPS in-line, beats on revs; guides Q3 EPS in-line; guides Q4 EPS...

yahoo.com     Aug 20, 2008   12 related          

8:55AM Security Bank announces suspension of quarterly dividends 4.00 : Co announces its Board of Directors has voted to suspend regular quarterly dividends on its common stock effective immediately and also voted to suspend...                    

InPlay: Suntech Power beats by $0.09, beats on revs; guides Q3 revs above consensus; guides FY08...

yahoo.com     Aug 20, 2008   14 related          

8:55AM Security Bank announces suspension of quarterly dividends 4.00 : Co announces its Board of Directors has voted to suspend regular quarterly dividends on its common stock effective immediately and also voted to suspend...                    

Technology For Dyslexics

cnpublications.net     Aug 20, 2008          

Ginger's spellchecker helps dyslexics get it right By Karin Kloosterman, Israel 21C, August 18, 2008 Spellcheckers on computer software did to language what calculators have done to math, unless you are one of the 15 percent of...                    

Rosetta Genomics Reports Second Quarter 2008 Financial Results

redorbit.com     Aug 19, 2008   4 related          

REHOVOT, Israel and JERSEY CITY, New Jersey, August 19 /PRNewswire-FirstCall/ -- Rosetta Genomics, Ltd. , a leading developer of microRNA-based diagnostic and therapeutic products, reported today its consolidated financial...                    

M. D. Anderson To Initiate Clinical Validation Study On Rosetta Genomics' MicroRNA-based...

medicalnewstoday.com     Aug 12, 2008   5 related          

Rosetta Genomics, Ltd. (NASDQ: ROSG), a leader in the development of microRNA-based diagnostic and therapeutic products, announced the initiation of a clinical validation study with The University of Texas M. D. Anderson Cancer...                    

InvestSource, Inc.: CLX Medical, Inc. Plans to Acquire ThyroTest(R) Rapid Screening Device

tmcnet.com     Aug 12, 2008   10 related          

Stocks in the News: CLX Medical, Inc. (OTCBB: CLXN), Optigenex Inc. (OTCBB: OPGX), Rosetta Genomics, Ltd. (NASDQ: ROSG), Perrigo Company (NASDAQ: PRGO) Aug 11, 2008 -- CLX Medical, Inc. (OTCBB: CLXN), which is focused on the...                    

U.S. Preventive Services Task Force Does Not Recommend PSA Screening in Elderly Men

cancerconsultants.com     Aug 5, 2008   3 related          

Members of the U.S. Preventive Services Task Force have concluded that there is still insufficient evidence to recommend PSA screening in men 75 years of age or younger. The details of these recommendations were published in...                    

Radiofrequency Ablation Effective for Primary Lung Tumors and Lung Metastases from Prostate Cancer

cancerconsultants.com     Aug 1, 2008   4 related          

The use of radiofrequency ablation for the treatment of lung cancer and lung metastases from breast, colon, and prostate cancers and melanoma is effective and safe for some patients. These results were recently published in the...                    

LegalView Unveils Details of a Breakthrough Mesothelioma Cancer Early Detection Test for...

prleap.com     Jul 31, 2008   6 related          

Denver, CO - LegalView informed mesothelioma blog readers of a new scientific test that may offer early diagnosis of mesothelioma cancer. The two organizations have completed the test that can determine between two similar...                    

1 2 3 4 5 next »